Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo

被引:40
作者
Gur, E [1 ]
Dremencov, E [1 ]
Lerer, B [1 ]
Newman, ME [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Psychiat, Biol Psychiat Lab, IL-91120 Jerusalem, Israel
关键词
venlafaxine; antidepressant; 5-HT; (5-hydroxytryptamine; serotonin); microdialysis; 5-HT1A receptor; cortex; hippocampus;
D O I
10.1016/S0014-2999(99)00164-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Venlafaxine is a dual serotonin (5-hydroxytryptamine, 5-HT) and noradrenaline uptake inhibitor which has been claimed to have an onset of antidepressant action which is faster than for other comparable drugs. The effects of venlafaxine on brain 5-HT levels in vivo have not yet been examined. Acute administration of venlafaxine to rats by i.p, injection resulted in dose-dependent increases in cortical and hippocampal 5-HT levels, as measured by in vivo microdialysis, over the range 5-20 mg/kg. The effect of venlafaxine (10 mg/kg i.p.) was potentiated by prior administration of pindolol (10 mg/kg s.c.) in hippocampus but not in frontal cortex. Daily administration of venlafaxine (5 mg/kg i.p.) for 4 weeks did not change basal 5-HT levels in either brain area. The effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT, 0.2. mg/kg s.c.) to reduce 5-HT levels was unaffected by chronic venlafaxine at this dose, indicating that there was no change in sensitivity of presynaptic 5-HT1A autoreceptors. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 49 条
[1]   The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram [J].
Arborelius, L ;
Nomikos, GG ;
Hertel, P ;
Salmi, P ;
Grillner, P ;
Hook, BB ;
Hacksell, U ;
Svensson, TH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (06) :630-640
[2]  
ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
[3]   (-)-Pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors [J].
Assie, MB ;
Koek, W .
NEUROPHARMACOLOGY, 1996, 35 (02) :213-222
[4]  
AUERBACH SB, 1995, N-S ARCH PHARMACOL, V352, P597
[5]   Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine:: a comparative study with paroxetine and desipramine [J].
Béïque, JC ;
de Montigny, C ;
Blier, P ;
Debonnel, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (03) :526-532
[6]   Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters [J].
Béïque, JC ;
Lavoie, N ;
de Montigny, C ;
Debonnel, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 349 (01) :129-132
[7]  
Bel N, 1996, J PHARMACOL EXP THER, V278, P1064
[8]   FLUVOXAMINE PREFERENTIALLY INCREASES EXTRACELLULAR 5-HYDROXYTRYPTAMINE IN THE RAPHE NUCLEI - AN INVIVO MICRODIALYSIS STUDY [J].
BEL, N ;
ARTIGAS, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (01) :101-103
[9]   CHRONIC TREATMENT WITH FLUVOXAMINE INCREASES EXTRACELLULAR SEROTONIN IN FRONTAL-CORTEX BUT NOT IN RAPHE NUCLEI [J].
BEL, N ;
ARTIGAS, F .
SYNAPSE, 1993, 15 (03) :243-245
[10]   Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response [J].
Blier, P ;
Bergeron, R ;
deMontigny, C .
NEUROPSYCHOPHARMACOLOGY, 1997, 16 (05) :333-338